[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Registration::
Contact us::
Site Facilities::
::
Impact Factor 2022: 1.4
Cite Score 2022: 2.1
SJR 2022: 0.347
SNIP 2022: 0.545
..
Publication Charge
►Publication Fee
..
In Press
 In Press Articles
..
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 10, Issue 4 (9-2019) ::
Caspian J Intern Med 2019, 10(4): 411-416 Back to browse issues page
Overexpression of cancer stem cell marker Lgr5 in colorectal cancer patients and association with pathologic findings
Ramin Shekarriz , Fatemeh Montazer , Reza Alizadeh-Navaei
Department of pathology, Iran University of medical science, Tehran, Iran , montazer.f@iums.ac.ir
Abstract:   (4194 Views)
Background: To determine the expression of cancer stem cell marker Leucine-rich repeat-containing G-protein coupled receptor 5 (Lgr5) in colorectal carcinoma samples compared to normal adjacent tissue and any possible association with clinicopathological findings.
Methods: This study was performed on forty samples of cancerous colorectal tissues (case group) and their adjacent normal mucosa (control group) in Imam Khomeini Hospital (Sari, Mazandaran, Iran). Expression of Lgr5 in tissue sections was done by immunohistochemistry. Statistical analysis was carried out using SPSS software.
Results: Forty colorectal cancer patients including 21 males (57.8±11.6 years) and 19 females (58.4±12.77 years) were enrolled. Lgr5 was overexpressed in tumoral samples than normal adjacent tissues (77.5% vs 27.5%, p<0.001). Also, no association was found between primary tumor, regional lymph nodes, invasion, histological type, grade, distant metastasis and IHC results. Patients with low Lgr5 expression had a better survival rate than patients with high expression but this was not statistically significant (p=0.121).
Conclusion:The higher immunoreactivity of Lgr5 in colorectal cancer tissues may indicate its role as a cancer stem cell marker in tumor carcinogenesis and patient’s survival however; Lgr5 is not associated with pathological prognostic variables.
Keywords: cancer stem cell, Lgr5, colorectal cancer
Full-Text [PDF 547 kb]   (924 Downloads)    
Type of Study: Original Article | Subject: Oncology
Received: 2018/12/25 | Accepted: 2019/06/18 | Published: 2019/09/25
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA



XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Shekarriz R, Montazer F, Alizadeh-Navaei R. Overexpression of cancer stem cell marker Lgr5 in colorectal cancer patients and association with pathologic findings. Caspian J Intern Med 2019; 10 (4) :411-416
URL: http://caspjim.com/article-1-1697-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 10, Issue 4 (9-2019) Back to browse issues page
Caspian Journal of Internal Medicine
Persian site map - English site map - Created in 0.07 seconds with 40 queries by YEKTAWEB 4645